billHR10405Event Wednesday, September 16, 2026Analyzed

To amend the Public Health Service Act to ensure that pediatric cancer experts are represented in State comprehensive cancer control coalitions, to direct the Secretary of Health and Human Services to establish a pediatric cancer advisory committee, and for other purposes.

Neutral

Summary

HR 10405, introduced in the House on 2026-09-16, would amend the Public Health Service Act to require pediatric cancer expert representation in state comprehensive cancer control coalitions and establish a pediatric cancer advisory committee at HHS. The bill is in early legislative stages, referred to the House Energy and Commerce Committee, with no funding authorized. Market impact is minimal and indirect, primarily affecting pediatric oncology-focused healthcare providers and research institutions.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR 10405 is a procedural, early-stage bill with no funding authorization, making near-term market impact minimal.
  • 2.The bill focuses on pediatric cancer care coordination, not on drug pricing, coverage mandates, or direct provider payments.
  • 3.No specific public companies are directly named or obligated by the bill's provisions.
  • 4.The bill's passage would not alter existing reimbursement models or create new revenue streams for healthcare companies.
  • 5.Investors should monitor committee action; any amendments adding funding or coverage provisions could change the market calculus.

Market Implications

The bill's impact on healthcare equities is negligible. No tickers meet the confidence threshold for inclusion because the causal chain from the bill to any public company's revenue or costs is too indirect. The bill does not alter reimbursement, coverage, or drug pricing, and it does not mandate specific provider payments. Healthcare providers like HCA Healthcare ($HCA) or UnitedHealth Group ($UNH) would only be affected if the advisory committee's recommendations led to future coverage mandates, which is speculative and years away. The bill's primary effect is administrative, not financial.

Full Analysis

HR 10405 was introduced on 2026-09-16 by Rep. Gottheimer (D-NJ) and cosponsored by Rep. Lawler (R-NY), then referred to the House Committee on Energy and Commerce. The bill mandates that state comprehensive cancer control coalitions include pediatric cancer experts and directs the HHS Secretary to establish a pediatric cancer advisory committee. No funding authorization is specified, and the bill remains at the committee referral stage with no further action. The legislative path forward includes committee hearings, markup, and potential floor votes in both chambers, followed by presidential action. The bill's impact on public companies is indirect and limited to potential long-term improvements in pediatric cancer care coordination, which could modestly benefit healthcare providers with pediatric oncology services and research institutions. No direct revenue or cost mechanisms are included, and the bill does not mandate coverage or reimbursement changes. Given the early stage and lack of funding, market impact is expected to be negligible in the near term.

Key Legislators

Rep. Gottheimer, Josh [D-NJ-5]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →